To test whether abnormal tau can drive this re-entrainment phenotype in the absence of Aβ pathology, we repeated the jet lag experiment with the PS19 mouse model, which carries a mutation driving aggressive tauopathy, but does not carry amyloidogenic mutations (Yoshiyama et al., 2007). The gene discussed is MAPT; the disease is tauopathy.